SCHEMBL31701883

SCHEMBL31701883

CN(C)C(=O)c1ccc(C2=CCNCC2)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WNT3A P56704 1/20 0.42
CCNT1 O60563 3/20 0.40
CDK9 P50750 3/20 0.40
TSHR P16473 2/20 0.40
CYP2D6 P10635 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
CDK4 P11802 1/20 0.38
CDK6 Q00534 1/20 0.38
QDPR P09417 1/20 0.38
KMT2A Q03164 1/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SIGMAR1 Q99720 2/20 0.36
MAP4K1 Q92918 1/20 0.36
HTR2C P28335 2/20 0.36
HRH3 Q9Y5N1 1/20 0.35
PDE10A Q9Y233 1/20 0.35
P4HA1 P13674 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171560 0.83 P4HA1 (0.54) WNT3ATSHRQDPRALDH1A1CYP1A2
SCHEMBL171555 0.82 NNMT (0.42) WNT3ACCNT1CDK9QDPRSIGMAR1
SCHEMBL22047337 0.82 SPR (0.47) WNT3ACCNT1CDK9QDPRKMT2A
SCHEMBL31702391 0.77 CDK4 (0.37) WNT3ACCNT1CDK9CDK4CDK6
SCHEMBL31700559 0.76 CCNT1 (0.40) WNT3ACCNT1CDK9CDK4CDK6
SCHEMBL13490342 0.75 WNT3A (0.43) WNT3ACCNT1CDK9TSHRCYP2D6
SCHEMBL31701401 0.75 HRH3 (0.36) CCNT1CDK9TSHRCDK4CDK6
SCHEMBL103834 0.74 CCR1 (0.48) WNT3AQDPRALDH1A1SIGMAR1HTR2C
SCHEMBL10068060 0.74 QDPR (0.59) WNT3AQDPRSIGMAR1HTR2CHRH3
SCHEMBL14544114 0.74 WNT3A (0.57) WNT3AQDPRSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250325677-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-23 US disclosed
US-20250320205-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325677-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 WNT3A 529/4885CCNT1 2041/4885CDK9 863/4885
US-20250320205-A1 STAT6 DEGRADERS STAT6, STAT1, STAT5B WNT3A 661/4885CCNT1 2164/4885CDK9 851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.